1. Home
  2. ISTR vs DBVT Comparison

ISTR vs DBVT Comparison

Compare ISTR & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ISTR
  • DBVT
  • Stock Information
  • Founded
  • ISTR 2006
  • DBVT 2002
  • Country
  • ISTR United States
  • DBVT France
  • Employees
  • ISTR N/A
  • DBVT N/A
  • Industry
  • ISTR Major Banks
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ISTR Finance
  • DBVT Health Care
  • Exchange
  • ISTR Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • ISTR 222.8M
  • DBVT 260.5M
  • IPO Year
  • ISTR 2014
  • DBVT N/A
  • Fundamental
  • Price
  • ISTR $22.62
  • DBVT $9.84
  • Analyst Decision
  • ISTR Buy
  • DBVT Buy
  • Analyst Count
  • ISTR 1
  • DBVT 4
  • Target Price
  • ISTR $27.00
  • DBVT $14.81
  • AVG Volume (30 Days)
  • ISTR 36.4K
  • DBVT 33.0K
  • Earning Date
  • ISTR 10-20-2025
  • DBVT 11-05-2025
  • Dividend Yield
  • ISTR 1.93%
  • DBVT N/A
  • EPS Growth
  • ISTR 46.46
  • DBVT N/A
  • EPS
  • ISTR 2.24
  • DBVT N/A
  • Revenue
  • ISTR $90,651,000.00
  • DBVT $3,800,000.00
  • Revenue This Year
  • ISTR $10.96
  • DBVT $1,743.46
  • Revenue Next Year
  • ISTR $61.82
  • DBVT $1,045.66
  • P/E Ratio
  • ISTR $10.19
  • DBVT N/A
  • Revenue Growth
  • ISTR 12.41
  • DBVT N/A
  • 52 Week Low
  • ISTR $15.39
  • DBVT $2.21
  • 52 Week High
  • ISTR $24.81
  • DBVT $12.78
  • Technical
  • Relative Strength Index (RSI)
  • ISTR 51.69
  • DBVT 54.64
  • Support Level
  • ISTR N/A
  • DBVT $9.58
  • Resistance Level
  • ISTR $23.16
  • DBVT $10.50
  • Average True Range (ATR)
  • ISTR 0.32
  • DBVT 0.52
  • MACD
  • ISTR -0.95
  • DBVT 0.07
  • Stochastic Oscillator
  • ISTR 95.44
  • DBVT 63.33

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: